Neuland Laboratories Limited

NSE:NEULANDLAB.NS

12564.5 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017201620152014201320122011201020092008
Operating Activities:
Net Income 3,000.7892,152.129821.6251,053.335529.225203.373139.344494.184420.029247.218268.073138.638.3149.38-98.14146.14
Depreciation & Amortization 596.999527.762490.402396.826312.801258.626221.035186.466157.426153.198149.386146.22148.91154.11135.5973.7
Deferred Income Tax 0000000000000000
Stock Based Compensation 0000000000000000
Change In Working Capital -907.318-91.722-675.849492.165-491.728154.702-400.192-375.684-191.737-387.647-219.832-31547.24-121.36-97.8-113.58
Accounts Receivables -86.629-1,343.279-171.001-300.75-294.993315.363-122.51-568.51272.278-120.97-214.287-64.370000
Inventory -711.885-140.233-176.024-280.603-268.932-175.663-399.752-78.378-132.589-199.866-12.4892.49-125.02-79.91-14.6-154.53
Accounts Payables 203.284543.595-397.171366.455-47.287-21.836386.157-2.091-278.2210000000
Other Working Capital -312.088848.19568.347707.063119.48436.838-0.44-297.306-59.148-187.781-207.343-317.49172.26-41.45-83.240.95
Other Non Cash Items 1,655.637-202.848-50.371-48.709223.11482.371152.49261.55562.547118.952246.197286.92288.93259.85212.66109.02
Operating Cash Flow 2,556.8792,385.321585.8071,893.617573.412699.072112.679366.521448.265131.721443.824256.77493.39341.98152.31215.28
Investing Activities:
Investments In Property Plant And Equipment -1,436.698-661.274-958.779-1,053.97-487.968-631.119-1,335.978-403.381-193.114-154.45-178.572-141.65-53.5-81.88-233.85-742.34
Acquisitions Net 12.63214.9134.3610.0857.83.7979.3611.3925.380000000
Purchases Of Investments -155.101-14.913-10.148-188.219-58.704-159.3880-14.97700000000
Sales Maturities Of Investments 3.36715.99816.606188.13450.904155.591202.8000000000
Other Investing Activites -60.1730.30110.878209.7331.172-141.175173.106-11.29-5.45313.158123.44971.061.351.140.450.37
Investing Cash Flow -1,575.8-614.975-937.082-844.237-486.796-772.294-1,162.872-414.671-198.567-141.292-55.123-70.59-52.15-80.74-233.4-741.97
Financing Activities:
Debt Repayment -394.402-356.237-222.607-1,260.275-223.522-1,006.11-282.658-280.351-310.582-295.807-278.411-475.51-386.21-259.7-356.27-82.55
Common Stock Issued 000001,245.05800.3760250.1761.0295.380.24003.86
Common Stock Repurchased 0000000000-101.51200000
Dividends Paid -128.299-64.149-38.49-25.66-49.49500-21.377-15.954-26.654-10.662000-22.1-15.78
Other Financing Activities -252.124-937.57638.312149.331218.213-119.1761,331.155358.21490.37983.7870.535181.11-51.0816.95482.56640.15
Financing Cash Flow -558.998-1,357.956377.215-1,136.604-54.804119.7721,048.49756.862-236.15711.502-389.03-199.02-437.05-242.75104.19545.68
Other Information:
Effect Of Forex Changes On Cash -0.4864.0690.618-0.4550.846-0.0520.146-0.10100000000
Net Change In Cash 712.633412.3926.558-87.67932.65846.498-1.558.71213.5411.931-0.329-12.844.1918.4923.118.99
Cash At End Of Period 1,167.954449.57450.91424.356112.03579.37732.87930.35521.6438.1026.1716.519.34152.7134.22111.12